Literature DB >> 10448782

A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study.

J S Krop1, J Coresh, L E Chambless, E Shahar, R L Watson, M Szklo, F L Brancati.   

Abstract

CONTEXT: The explanation for the excess risk for diabetic renal disease in blacks is uncertain.
OBJECTIVES: To compare the incidence of early renal function decline in black and white adults with diabetes and to examine possible explanatory factors for racial differences.
DESIGN: Prospective cohort study.
SETTING: Four US communities participating in the Atherosclerosis Risk in Communities study. PARTICIPANTS: Community-based sample of 1434 diabetic adults aged 45 to 64 years. MEASUREMENTS: Detailed baseline assessment using structured interview, results of physical examination, and laboratory measurements. MAIN OUTCOME: Development of early renal function decline defined by an increase in serum creatinine of at least 35.4 micromol/L (0.4 mg/dL) during 3 years of follow-up.
RESULTS: During 3 years of follow-up, early renal function decline developed in 45 blacks (28.4 per 1000 person-years [PY]) and 25 whites (9.6 per 1000 PY). After adjustment for age, sex, and baseline serum creatinine level, early renal function decline was more than 3 times as likely to develop in blacks than whites (odds ratio, 3.15; 95% confidence interval, 1.86-5.33). Additional adjustment for education, household income, health insurance, fasting glucose level, mean systolic blood pressure, smoking history, and physical activity level reduced the relative odds in blacks to 1.38 (95% confidence interval, 0.71-2.69), corresponding to a 82% reduction in excess risk.
CONCLUSIONS: These data suggest that early renal function decline is 3 times more likely to develop in blacks than whites and that potentially modifiable factors, including lower socioeconomic status, suboptimal health behaviors, and suboptimal control of glucose level and blood pressure, account for more than 80% of this disparity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448782     DOI: 10.1001/archinte.159.15.1777

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  61 in total

1.  Racial differences in the incidence of chronic kidney disease.

Authors:  Paul Muntner; Britt Newsome; Holly Kramer; Carmen A Peralta; Yongin Kim; David R Jacobs; Catarina I Kiefe; Cora E Lewis
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Screening and prevention of chronic kidney disease.

Authors:  Errol D Crook; David O Washington; John M Flack
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

3.  Race differences in access to health care and disparities in incident chronic kidney disease in the US.

Authors:  Kira Evans; Josef Coresh; Lori D Bash; Tiffany Gary-Webb; Anna Köttgen; Kathryn Carson; L Ebony Boulware
Journal:  Nephrol Dial Transplant       Date:  2010-08-05       Impact factor: 5.992

4.  Poverty and racial disparities in kidney disease: the REGARDS study.

Authors:  William M McClellan; Britt B Newsome; Leslie A McClure; George Howard; Nataliya Volkova; Paul Audhya; David G Warnock
Journal:  Am J Nephrol       Date:  2010-05-31       Impact factor: 3.754

Review 5.  The impact of disadvantage on the development and progression of diabetic kidney disease.

Authors:  E J Weil; J M Curtis; R L Hanson; W C Knowler; R G Nelson
Journal:  Clin Nephrol       Date:  2010-11       Impact factor: 0.975

6.  The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III).

Authors:  David Martins; Naureen Tareen; Ashraf Zadshir; Deyu Pan; Roberto Vargas; Allen Nissenson; Keith Norris
Journal:  Am J Kidney Dis       Date:  2006-06       Impact factor: 8.860

7.  A critical evaluation of chronic kidney disease--should isolated reduced estimated glomerular filtration rate be considered a 'disease'?

Authors:  Emilio D Poggio; Andrew D Rule
Journal:  Nephrol Dial Transplant       Date:  2008-12-22       Impact factor: 5.992

8.  Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes.

Authors:  Claire Gerber; Xuan Cai; Jungwha Lee; Timothy Craven; Julia Scialla; Nao Souma; Anand Srivastava; Rupal Mehta; Amanda Paluch; Alexander Hodakowski; Rebecca Frazier; Mercedes R Carnethon; Myles Selig Wolf; Tamara Isakova
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-24       Impact factor: 8.237

9.  Defining incident chronic kidney disease in the research setting: The ARIC Study.

Authors:  Lori D Bash; Josef Coresh; Anna Köttgen; Rulan S Parekh; Tibor Fulop; Yaping Wang; Brad C Astor
Journal:  Am J Epidemiol       Date:  2009-06-17       Impact factor: 4.897

10.  Kidney disease and the cumulative burden of life course socioeconomic conditions: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  David A Shoham; Suma Vupputuri; Jay S Kaufman; Abhijit V Kshirsagar; Ana V Diez Roux; Josef Coresh; Gerardo Heiss
Journal:  Soc Sci Med       Date:  2008-07-28       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.